CS logo
small CS logo
Ospedale A. Perrino

Brindisi, Italy
Hospital in Brindisi
Strada Statale 7 per Mesagne, 72100 Brindisi BR

About Ospedale A. Perrino


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Ospedale A. Perrino


During the past decade, Ospedale A. Perrino conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 8 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 5 clinical trials were completed. i.e. 35.7% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Ospedale A. Perrino" #1 sponsor was "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 6 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 3 trials sponsored, "Fondazione Italiana Linfomi ONLUS" with 3 trials sponsored, "Agios Pharmaceuticals, Inc." with 2 trials sponsored and "Celgene" with 2 trials sponsored. Other sponsors include 34 different institutions and companies that sponsored additional 38 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale A. Perrino" #1 collaborator was "Clinical Research Technology S.r.l." with 4 trials as a collaborator, "NSABP Foundation Inc" with 2 trials as a collaborator, "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 1 trials as a collaborator, "Acute Leukemia French Association" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 26 trials.

Clinical Trials Conditions at Ospedale A. Perrino


According to Clinical.Site data, the most researched conditions in "Ospedale A. Perrino" are "Breast Cancer" (8 trials), "Leukemia" (4 trials), "Breast Neoplasms" (2 trials), "COVID" (2 trials) and "Metastatic Breast Cancer" (2 trials). Many other conditions were trialed in "Ospedale A. Perrino" in a lesser frequency.

Clinical Trials Intervention Types at Ospedale A. Perrino


Most popular intervention types in "Ospedale A. Perrino" are "Drug" (43 trials), "Procedure" (5 trials), "Radiation" (5 trials), "Other" (4 trials) and "Behavioral" (3 trials). Other intervention types were less common.
The name of intervention was led by "Letrozole" (4 trials), "mitoxantrone hydrochloride" (4 trials), "radiation therapy" (4 trials), "Exemestane" (3 trials) and "allogeneic bone marrow transplantation" (3 trials). Other intervention names were less common.

Clinical Trials Genders at Ospedale A. Perrino


The vast majority of trials in "Ospedale A. Perrino" are 44 trials for "All" genders and 11 trials for "Female" genders.

Clinical Trials Status at Ospedale A. Perrino


Currently, there are NaN active trials in "Ospedale A. Perrino". undefined are not yet recruiting, 12 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Ospedale A. Perrino, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Ospedale A. Perrino, 0 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".

Departments of Ospedale A. Perrino


Ospedale A. Perrino has several departments that took part in Clinical trials: "Stabilimento "Perrino" - Brindisi - Brindisi (Br) Oncologia Medica" - 2 trials